IMM.L - ImmuPharma plc
| Previous close | 9.95 |
| Open | 9.68 |
| Bid | 9.80 x 0 |
| Ask | 10.25 x 0 |
| Day's range | 9.60 - 10.70 |
| 52-week range | 6.91 - 32.29 |
| Volume | 726,160 |
| Avg. volume | 604,508 |
| Market cap | 16.778M |
| Beta (5Y monthly) | 0.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -5.10 |
| Earnings date | 30 May 2019 - 03 Jun 2019 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.00 |
- Simply Wall St.
Those Who Purchased ImmuPharma (LON:IMM) Shares Five Years Ago Have A 72% Loss To Show For It
It is doubtless a positive to see that the ImmuPharma plc (LON:IMM) share price has gained some 50% in the last three...
- Reuters
ImmuPharma licenses lupus drug Lupuzor to Avion in the United States
British pharmaceutical firm ImmuPharma said on Thursday it had signed a licensing and development agreement for Lupuzor, a first-in-class treatment for auto-immune disease Lupus, with U.S. company Avion Pharmaceuticals. Avion and ImmuPharma will co-develop Lupuzor, including a new Phase III trail, and Avion will commercialise the drug exclusively in the United States, ImmuPharma said.
- Simply Wall St.
Does ImmuPharma plc's (LON:IMM) CEO Salary Compare Well With Others?
Dimitri Dimitriou is the CEO of ImmuPharma plc (LON:IMM). This report will, first, examine the CEO compensation levels...
- Simply Wall St.
Is ImmuPharma (LON:IMM) Using Debt Sensibly?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
- Simply Wall St.
Those Who Purchased ImmuPharma (LON:IMM) Shares Five Years Ago Have A 80% Loss To Show For It
We're definitely into long term investing, but some companies are simply bad investments over any time frame. We don't...
- Simply Wall St.
Is ImmuPharma plc's (LON:IMM) CEO Pay Fair?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Dimitri Dimitriou is the CEO of ImmuPharma plc (LON:IMM). This report will, first, examine...
